Ensysce Biosciences Inc. (ENSC)
NASDAQ · Healthcare
Ensysce Biosciences Inc. Operating Income 2020–2025
Ensysce Biosciences Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Ensysce Biosciences Inc. operating income for the quarter ending March 31, 2026 was -3.6 M, a 81.05% increase year-over-year.
- Ensysce Biosciences Inc. operating income for the twelve months ending March 31, 2026 was -11.0 M, a 88.05% increase year-over-year.
- Ensysce Biosciences Inc. annual operating income for 2025 was -10.2 M, a 52.17% increase from 2024.
- Ensysce Biosciences Inc. annual operating income for 2024 was -6.7 M, a 37.21% decrease from 2023.
- Ensysce Biosciences Inc. annual operating income for 2023 was -10.7 M, a 55.75% decrease from 2022.
- Ensysce Biosciences Inc. annual operating income for 2022 was -24.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ensysce Biosciences Inc. Operating Income — FAQ
Ensysce Biosciences Inc. (ENSC) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Ensysce Biosciences Inc.'s operating income?
Ensysce Biosciences Inc. (ENSC) reported operating income of -$10M for fiscal 2025.
Where can I see ENSC's operating income history?
The chart and table above show Ensysce Biosciences Inc.'s operating income by year and by quarter, including the growth rate.